<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Genetics</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D246A3CC-23F7-4B0D-83FD-5E224F5C0027"><gtr:id>D246A3CC-23F7-4B0D-83FD-5E224F5C0027</gtr:id><gtr:firstName>Yuri</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Dubrova</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1897EED2-6B48-433F-9260-2B127DB1EDD2"><gtr:id>1897EED2-6B48-433F-9260-2B127DB1EDD2</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Gilbert</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300477"><gtr:id>86D35261-B6E6-401E-A938-C32B682CC013</gtr:id><gtr:title>Development of a novel approach for monitoring germline mutation induction in mice by chemical mutagens and anticancer d</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300477</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>278794</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Parlamentary Event - London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>17D3581D-41E6-455E-9B3C-8E99A50D2638</gtr:id><gtr:impact>Personal presentaion by Dr Colin Glen

The technique developed at Leicester was presented and discussed</gtr:impact><gtr:outcomeId>1B04213FEFF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>284624</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C23912/A12262</gtr:fundingRef><gtr:id>68AEFB8F-DC90-40F3-ABDA-863D037C3914</gtr:id><gtr:outcomeId>Jshg5Dkv17g</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>431886</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (The effects of ionising radiation on copy number variation in the mouse germline)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>23C0CD19-8FC9-47DF-8C0C-51E25E748CEF</gtr:id><gtr:outcomeId>CW3Xju47sWs0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>206874</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>9B53E9F4-8CE4-4BC9-919E-33F6D9D990D3</gtr:id><gtr:outcomeId>09FBE6A05A60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>2FC0F1CA-776F-40AC-8C51-6C268E29304A</gtr:id><gtr:outcomeId>BM9EWfUxcfk0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Single-molecule PCR technique for in vivo monitoring of mutation induction in the germline of male mice exposed to anticancer drugs</gtr:description><gtr:id>AAFB2036-5DCE-420A-884A-774AE09C419A</gtr:id><gtr:impact>Improved estimates of the genetic risk of human exposure to anticancer drugs</gtr:impact><gtr:outcomeId>B906ACF78D7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Single-molecule PCR</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EB4BE4AC-DD6F-4715-B09C-2A3DFC509557</gtr:id><gtr:title>The combined effects of xeroderma pigmentosum C deficiency and mutagens on mutation rates in the mouse germ line.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/203ff75889318728c798c75ec5713ae7"><gtr:id>203ff75889318728c798c75ec5713ae7</gtr:id><gtr:otherNames>Miccoli L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>DE39EB61BF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E95ACD99-E332-4CF4-8036-62BC9820042C</gtr:id><gtr:title>Stage-specificity of spontaneous mutation at a tandem repeat DNA locus in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6fab8f2ccf32b702abb75984178e742"><gtr:id>a6fab8f2ccf32b702abb75984178e742</gtr:id><gtr:otherNames>Shanks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>3368396D5C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EFD6AFF-A951-4829-9654-151ED419FD91</gtr:id><gtr:title>The effects of MSH2 deficiency on spontaneous and radiation-induced mutation rates in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e28af027fafc13e5bf74c40714aac6b"><gtr:id>0e28af027fafc13e5bf74c40714aac6b</gtr:id><gtr:otherNames>Burr KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>AD7E66DE2AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17B3DF17-124D-4E48-80C8-CD9362BAD6B0</gtr:id><gtr:title>Maternal effects of the scid mutation on radiation-induced transgenerational instability in mice.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f2b8128d6a0ad52f04694d7611b92e8"><gtr:id>8f2b8128d6a0ad52f04694d7611b92e8</gtr:id><gtr:otherNames>Hatch T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>93772F8793D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5088603-C100-4E0C-A699-135E99B152A0</gtr:id><gtr:title>The effects of in utero irradiation on mutation induction and transgenerational instability in mice.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd78fa82b889c504b09cd623b983181a"><gtr:id>bd78fa82b889c504b09cd623b983181a</gtr:id><gtr:otherNames>Barber RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>7A6BE3ADC6A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>984B8BDE-D698-42BD-BAD9-FD84204926DD</gtr:id><gtr:title>The effects of Atm haploinsufficiency on mutation rate in the mouse germ line and somatic tissue.</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25551c5b9d479afcb16a01fcebd653d8"><gtr:id>25551c5b9d479afcb16a01fcebd653d8</gtr:id><gtr:otherNames>Ahuja AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>B02CE739992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D678AD1-F6F5-428A-B51D-9738D0E1894E</gtr:id><gtr:title>Single-molecule PCR analysis of germ line mutation induction by anticancer drugs in mice.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7297f7e7ca95b19248522e951bfa0e0"><gtr:id>e7297f7e7ca95b19248522e951bfa0e0</gtr:id><gtr:otherNames>Glen CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>502B5AC4C8B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCC5E4FF-1BBC-4221-AD9B-DDEDF0CD0C11</gtr:id><gtr:title>Paternal exposure to ethylnitrosourea results in transgenerational genomic instability in mice.</gtr:title><gtr:parentPublicationTitle>Environmental and molecular mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9bc6c018a4e2a02e8ff6045caa9e3da"><gtr:id>d9bc6c018a4e2a02e8ff6045caa9e3da</gtr:id><gtr:otherNames>Dubrova YE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0893-6692</gtr:issn><gtr:outcomeId>8BDB93DDFCF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300477</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>